…
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Colgate-Palmolive Company manufactures and markets oral care, personal care, home care and pet nutrition products globally under well-known consumer brands. Long-term growth may be driven by brand strength, product innovation and premiumization, expanding e-commerce penetration and market share gains in emerging markets. The company appears positioned to generate steady cash flow from recurring consumer demand and broad distribution, which may appeal to investors seeking defensive exposure.
Key risks include margin pressure from commodity and freight cost volatility, foreign-exchange exposure, intensifying competition from multinational and private-label brands, and slower discretionary consumer spending in key markets.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 3059.00M | 3956.00M | 3392.00M | 2660.00M | 3087.00M |
| Minority interest | -129.00M | -160.00M | -155.00M | -182.00M | -172.00M |
| Net income | 2132.00M | 2889.00M | 2300.00M | 1785.00M | 2166.00M |
| Selling general administrative | 7798.00M | 5090.00M | 4866.00M | 6560.00M | 4410.00M |
| Selling and marketing expenses | - | 2720.00M | 2371.00M | - | 1997.00M |
| Gross profit | 12251.00M | 12106.00M | 11251.00M | 10248.00M | 10375.00M |
| Reconciled depreciation | 630.00M | 605.00M | 567.00M | 545.00M | 556.00M |
| Ebit | 3326.00M | 4248.00M | 3679.00M | 4335.00M | 4474.00M |
| Ebitda | 3956.00M | 4853.00M | 4246.00M | 4880.00M | 5030.00M |
| Depreciation and amortization | 630.00M | 605.00M | 567.00M | 545.00M | 556.00M |
| Operating income | 4348.00M | 4383.00M | 4131.00M | 4335.00M | 4474.00M |
| Other operating expenses | 16034.00M | 15718.00M | 15326.00M | 14353.00M | 13518.00M |
| Interest expense | 267.00M | 292.00M | 287.00M | 167.00M | 192.00M |
| Tax provision | 798.00M | 907.00M | 937.00M | 693.00M | 749.00M |
| Interest income | 192.00M | 67.00M | 55.00M | 153.00M | 175.00M |
| Net interest income | -192.00M | -225.00M | -232.00M | -153.00M | -175.00M |
| Non recurring | - | - | - | 721.00M | - |
| Income tax expense | 798.00M | 907.00M | 937.00M | 693.00M | 749.00M |
| Total revenue | 20382.00M | 20101.00M | 19457.00M | 17967.00M | 17421.00M |
| Total operating expenses | 7903.00M | 7723.00M | 7120.00M | 6634.00M | 6472.00M |
| Cost of revenue | 8131.00M | 7995.00M | 8206.00M | 7719.00M | 7046.00M |
| Total other income expense net | -1289.00M | -427.00M | -739.00M | -1675.00M | -1387.00M |
| Net income from continuing ops | 2261.00M | 3049.00M | 2455.00M | 1967.00M | 2338.00M |
| Net income applicable to common shares | 2132.00M | 2889.00M | 2300.00M | 1785.00M | 2166.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 16330.00M | 16046.00M | 16393.00M | 15731.00M | 15040.00M |
| Intangible assets | 1536.00M | 1756.00M | 1887.00M | 1920.00M | 2462.00M |
| Other current assets | 714.00M | 553.00M | 614.00M | 760.00M | 576.00M |
| Total liab | 15965.00M | 15502.00M | 15436.00M | 14925.00M | 14069.00M |
| Total stockholder equity | 365.00M | 544.00M | 609.00M | 401.00M | 609.00M |
| Deferred long term liab | - | - | - | 383.00M | 395.00M |
| Other current liab | 5736.00M | 2622.00M | 2282.00M | 2295.00M | 4000.00M |
| Common stock | 1466.00M | 1466.00M | 1466.00M | 1466.00M | 1466.00M |
| Capital stock | 1466.00M | 1466.00M | 1466.00M | 1466.00M | 1466.00M |
| Retained earnings | 26595.00M | 26145.00M | 25289.00M | 24573.00M | 24350.00M |
| Other liab | - | - | - | 1783.00M | 2824.00M |
| Good will | 3122.00M | 3272.00M | 3410.00M | 3352.00M | 3284.00M |
| Other assets | 1303.00M | 669.00M | - | 1039.00M | 1167.00M |
| Cash | 1288.00M | 1096.00M | 966.00M | 775.00M | 832.00M |
| Cash and equivalents | 1288.00M | 1096.00M | - | 775.00M | 832.00M |
| Total current liabilities | 5736.00M | 5759.00M | 4741.00M | 3979.00M | 4000.00M |
| Current deferred revenue | - | - | 1410.00M | - | -1667.00M |
| Net debt | 6700.00M | 7416.00M | 8098.00M | 8124.00M | 6413.00M |
| Short term debt | 1235.00M | 767.00M | 425.00M | 133.00M | 188.00M |
| Short long term debt | 1117.00M | 660.00M | 330.00M | 25.00M | 51.00M |
| Short long term debt total | 8554.00M | 8512.00M | 9064.00M | 8899.00M | 7245.00M |
| Other stockholder equity | 54.00M | -23177.00M | -22209.00M | -21583.00M | -20821.00M |
| Property plant equipment | 4660.00M | 4951.00M | - | 4307.00M | 3730.00M |
| Total current assets | 5709.00M | 5317.00M | 5279.00M | 5113.00M | 4397.00M |
| Net tangible assets | - | - | - | -4871.00M | -5137.00M |
| Short term investments | 107.00M | 160.00M | 179.00M | 175.00M | 34.00M |
| Net receivables | 1675.00M | 1521.00M | 1586.00M | 1504.00M | 1297.00M |
| Long term debt | 6871.00M | 7289.00M | 8219.00M | 8766.00M | 7245.00M |
| Inventory | 2032.00M | 1987.00M | 1934.00M | 2074.00M | 1692.00M |
| Accounts payable | 2089.00M | 1805.00M | 1698.00M | 1551.00M | 1479.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 405.00M | 362.00M |
| Accumulated other comprehensive income | - | -4222.00M | -3937.00M | -4055.00M | -4386.00M |
| Common stock total equity | - | - | - | 1466.00M | 1466.00M |
| Retained earnings total equity | - | - | - | 24573.00M | 24350.00M |
| Treasury stock | - | - | - | - | -24089.00M |
| Non currrent assets other | 1303.00M | 1003.00M | 447.00M | 904.00M | 1167.00M |
| Non current assets total | 10621.00M | 10729.00M | 11114.00M | 10618.00M | 10643.00M |
| Capital lease obligations | 566.00M | 563.00M | 515.00M | 505.00M | 588.00M |
| Long term debt total | 7319.00M | 7289.00M | - | 8766.00M | 7245.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 54.00M | -534.00M | -772.00M | -1601.00M | -592.00M |
| Change to liabilities | - | - | - | -115.00M | 14.00M |
| Total cashflows from investing activities | -817.00M | -534.00M | - | -1601.00M | -592.00M |
| Net borrowings | -456.00M | -408.00M | - | 1647.00M | -175.00M |
| Total cash from financing activities | -3256.00M | -3389.00M | -2793.00M | -952.00M | -2774.00M |
| Change to operating activities | - | - | - | -51.00M | -55.00M |
| Net income | 2132.00M | 3049.00M | 2300.00M | 1967.00M | 2338.00M |
| Change in cash | 192.00M | 130.00M | 191.00M | -57.00M | -56.00M |
| Begin period cash flow | 1096.00M | 966.00M | 775.00M | 832.00M | 888.00M |
| End period cash flow | 1288.00M | 1096.00M | 966.00M | 775.00M | 832.00M |
| Total cash from operating activities | 4198.00M | 4107.00M | 3745.00M | 2556.00M | 3325.00M |
| Depreciation | 630.00M | 605.00M | 567.00M | 545.00M | 556.00M |
| Other cashflows from investing activities | -14.00M | 37.00M | - | -905.00M | -25.00M |
| Dividends paid | 1823.00M | 1789.00M | 1749.00M | 1691.00M | 1679.00M |
| Change to inventory | 109.00M | -100.00M | 194.00M | -333.00M | -72.00M |
| Change to account receivables | -16.00M | -56.00M | -37.00M | -227.00M | -84.00M |
| Sale purchase of stock | -1210.00M | -1739.00M | -1128.00M | -1308.00M | -1320.00M |
| Other cashflows from financing activities | 132.00M | 547.00M | 398.00M | 2453.00M | -24.00M |
| Change to netincome | - | - | - | 770.00M | 800.00M |
| Capital expenditures | 564.00M | 561.00M | 705.00M | 696.00M | 567.00M |
| Change receivables | - | - | - | -227.00M | -84.00M |
| Cash flows other operating | - | - | - | -51.00M | -55.00M |
| Cash and cash equivalents changes | - | - | - | 3.00M | -41.00M |
| Change in working capital | 284.00M | 344.00M | 455.00M | -726.00M | -197.00M |
| Stock based compensation | 155.00M | 135.00M | 122.00M | 125.00M | 135.00M |
| Other non cash items | 1261.00M | 51.00M | 399.00M | 723.00M | 625.00M |
| Free cash flow | 3634.00M | 3546.00M | 3040.00M | 1860.00M | 2758.00M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CL Colgate-Palmolive Company |
0.98 1.02% |
97.55 | 34.66 | 21.46 | 3.30 | 296.88 | 3.64 | 19.95 |
| PG Procter & Gamble Company |
0.98 0.59% |
166.38 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
-25.50 5.05% |
479.50 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
-0.45 0.45% |
99.92 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
- -% |
66.00 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
300 Park Avenue, New York, NY, United States, 10022-7499
212 310 2000
33600
| Name | Title | Year Born |
|---|---|---|
| Mr. Noel R. Wallace | Chairman, CEO & Pres | 1964 |
| Mr. Stanley J. Sutula III | Chief Financial Officer | 1966 |
| Ms. Jennifer M. Daniels | Chief Legal Officer & Sec. | 1964 |
| Mr. Panagiotis Tsourapas | Group Pres of Europe & Developing Markets | 1965 |
| Ms. Prabha Parameswaran | Group Pres of Growth & Strategy | 1959 |
| Mr. Gregory Malcolm | VP, Controller & Principal Accounting Officer | 1967 |
| Mr. Stephan Habif | Chief Technology Officer | NA |
| Mr. Mike Crowe | Chief Information Officer | NA |
| John Faucher | Chief Investor Relations Officer | NA |
| Valerie Haliburton | VP of Global Ethics & Compliance | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.